Quote:

---

BUT the only thing now that will trigger the SP is revenue

---

While it is true that most of the things that investors think should move the SP, wont (Estrada, first injected,etc) revenue is not the only catalyst to the share price. IMO.

Other items that I believe would have a positive influence on share price:

1) Rapid enrollment of the Brazil trials

2) Same for LH trial.

3) Strong interim results of any of the trials

4) A beneficial partnership

5) BTD (even though I feel this is a longshot today)

6) Acceptance of the BLA filing